Microbiome Testing Kit Market Is Supported By Major Drivers, With Expected Revenue Of $4.8 Billion By 2030
What Are The Anticipated Developments In The Microbiome Testing Kit Market’s Size And Overall Value Through 2030?
The microbiome testing kit market size has grown exponentially in recent years. It will grow from $1.63 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 24.3%. The growth in the historic period can be attributed to advancements in microbiome research, consumer wellness trends, DNA sequencing accessibility, digestive health awareness, research funding growth.
The microbiome testing kit market size is expected to see exponential growth in the next few years. It will grow to $4.8 billion in 2030 at a compound annual growth rate (CAGR) of 24.0%. The growth in the forecast period can be attributed to precision nutrition demand, AI-driven microbiome analytics, chronic disease prevention focus, e-commerce health platforms, personalized healthcare models. Major trends in the forecast period include growth of at-home diagnostic testing, personalized nutrition and wellness insights, expansion of gut health applications, preventive health screening adoption, increased consumer health awareness.
Claim Your Free Report Sample Today:
What Are The Leading Drivers To Growth In The Microbiome Testing Kit Market Landscape?
The increasing demand for personalized medicine is expected to propel the growth of the microbiome testing kit market going forward. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to an individual’s unique genetic makeup, lifestyle, and environment. The increasing adoption of personalized medicine is primarily due to advancements in genomics, which enable precise identification of genetic variations and tailored treatments for individuals. Microbiome testing kits enhance personalized medicine by offering individualized insights into a person’s microbial composition, making them ideal for tailored health management. They reduce guesswork in dietary and lifestyle interventions by providing precise, data-driven recommendations, improving overall wellness and disease prevention. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing demand for personalized medicine is driving the growth of the microbiome testing kit market.
How Is The Microbiome Testing Kit Market Segmented To Assess Performance Across Different Product, Application, Or Regional Categories?
The microbiome testing kit market covered in this report is segmented –
1) By Product Type: At-Home Testing, Laboratory-Based Testing
2) By Sample Type: Stool, Saliva, Skin, Other Sample Types
3) By Application: Gut Health, Skin Health, Nutrition And Diet, Disease Risk Assessment, Other Applications
4) By Distribution Channel: Online, Pharmacies, Retail Stores, Other Distribution Channel
5) By End-User: Individuals, Hospitals And Clinics, Research And Academic Institutes, Other End-Users
Subsegments:
1) By At-Home Testing: Gut Health Analysis, Digestive Function Assessment, Personalized Nutrition Guidance, Probiotic Response Evaluation
2) By Laboratory-Based Testing Kits: Microbial Diversity Profiling, Pathogen Detection, Metabolic Activity Analysis, Antibiotic Resistance Screening
What Influential Trends Are Gaining Momentum Within The Microbiome Testing Kit Market?
Major companies operating in the microbiome testing kit market are focusing on developing innovative solutions, such as next-generation sequencing-based gut microbiome analysis, to provide personalized insights into gut health and dietary recommendations. Next-generation sequencing-based gut microbiome analysis is a method that rapidly decodes the deoxyribonucleic acid of all microbes in the gut to identify their types, abundance, and potential impact on health. For instance, in January 2025, CJ Bioscience Inc., a South Korea-based biotechnology company, launched SMILE GUT, a direct-to-consumer gut microbiome testing kit designed to offer personalized insights into gut health. The kit employs next-generation sequencing and artificial intelligence to examine stool samples and generates a gut microbiome index score that reflects microbial diversity, the balance between beneficial and harmful bacteria, and alignment with healthy gut profiles. It provides tailored health recommendations, including probiotic guidance and dietary suggestions, with results delivered within 14 business days, enabling users to proactively manage their gut health.
Who Are The Top-Performing Companies Driving Growth In The Microbiome Testing Kit Market?
Major companies operating in the microbiome testing kit market are OraSure Technologies Inc., Genova Diagnostics Inc., Ombre Health Inc., Viome Inc., Zymo Research Corporation, EasyDNA Pty Ltd., Psomagen Inc., DayTwo Ltd., Atlas Biomed Group Limited., BIOHM Health Inc., Mapmygenome India Limited, Biomes NGS GmbH, Carbiotix AB, CosmosID Inc., Juno Bio Ltd., Microba Life Sciences Limited., Sun Genomics Inc., Unseen Bio ApS, InnerBuddies, MyMicroZoo B.V.
Get Your In-Depth Microbiome Testing Kit Market Report Now:
Which Geographic Markets Are Contributing Most Significantly To The Progress Of The Microbiome Testing Kit Market?
North America was the largest region in the personalized genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the microbiome testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment